• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分权管理药品:印度尼西亚基层医疗环境中国家政策与地方实践之间的差异

Managing medicines in decentralization: discrepancies between national policies and local practices in primary healthcare settings in Indonesia.

作者信息

Fanda Relmbuss Biljers, Probandari Ari, Kok Maarten Olivier, Bal Roland A

机构信息

Center for Health Policy and Management, Universitas Gadjah Mada, Medika, Sendowo, Sinduadi, Mlati, Sleman, Yogyakarta, Special Region of Yogyakarta, 55281, Indonesia.

Healthcare Governance Department, Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, Rotterdam, South Holand, 3062 PA, The Netherlands.

出版信息

Health Policy Plan. 2025 Mar 7;40(3):346-357. doi: 10.1093/heapol/czae114.

DOI:10.1093/heapol/czae114
PMID:39576064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11886838/
Abstract

In Indonesia, primary health centres (PHCs) are mandated to provide essential medicines to ensure equal access to medication for all Indonesians, as stated in the national medicine policy. However, limited information is available regarding the actual practices of health workers within the context of decentralized governance. This paper investigates the discrepancies between national policies and local practices in two Indonesian districts, shedding light on coping mechanisms employed in each phase of medicine management within PHCs. The mixed-method study began by identifying pertinent policies addressing medicine management in PHCs. Subsequently, panel data on patient visits to tuberculosis, maternal and neonatal health (MNH), and noncommunicable disease (NCD) services were collected from 2019 to 2022. After analysing the panel data, interviews were conducted with 56 health workers including physicians, nurses, pharmacists, midwives, and public health programme managers regarding their views on fluctuations in medicine stocks and the patient visit data. These participants included pharmacists and programme managers specializing in tuberculosis, MNH, and NCD care and were affiliated with PHCs and district health offices. Our findings highlight the occasional unavailability of essential medicines in PHCs, with stockouts being attributed to supplier shortages at provincial and national levels and to variations in the capacity of the local health system. Low-skilled pharmaceutical staff are a contributing factor in each phase of medicine management. Additionally, health workers employ coping mechanisms, such as deviating from policy on the use of capitation funds to purchase medicines, to manage temporary stockouts. To tackle systemic stockouts, central government should prioritize capacity-building among health workers, by establishing a continuous and easily accessible local learning system.

摘要

在印度尼西亚,正如国家药品政策所规定的,初级卫生保健中心(PHC)被要求提供基本药物,以确保所有印度尼西亚人都能平等获得药物治疗。然而,关于权力下放治理背景下卫生工作者的实际做法,可获取的信息有限。本文调查了印度尼西亚两个地区国家政策与地方实践之间的差异,揭示了初级卫生保健中心药品管理各阶段所采用的应对机制。这项混合方法研究首先确定了与初级卫生保健中心药品管理相关的政策。随后,收集了2019年至2022年期间患者前往结核病、孕产妇和新生儿健康(MNH)以及非传染性疾病(NCD)服务机构就诊的面板数据。在分析面板数据之后,对56名卫生工作者进行了访谈,这些卫生工作者包括医生、护士、药剂师、助产士和公共卫生项目管理人员,询问他们对药品库存波动和患者就诊数据的看法。这些参与者包括专门从事结核病、孕产妇和新生儿健康以及非传染性疾病护理的药剂师和项目管理人员,他们隶属于初级卫生保健中心和地区卫生办公室。我们的研究结果凸显了初级卫生保健中心基本药物偶尔缺货的情况,缺货原因包括省级和国家级供应商短缺以及地方卫生系统能力的差异。低技能的药学人员是药品管理各阶段的一个促成因素。此外,卫生工作者采用应对机制,例如偏离人头费资金用于购买药品的政策,来管理临时缺货情况。为了解决系统性缺货问题,中央政府应通过建立一个持续且易于使用的地方学习系统,将卫生工作者的能力建设作为优先事项。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf3/11886838/4add7c6f5271/czae114f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf3/11886838/3f1ec36ee724/czae114f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf3/11886838/9d5e615eefd9/czae114f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf3/11886838/4add7c6f5271/czae114f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf3/11886838/3f1ec36ee724/czae114f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf3/11886838/9d5e615eefd9/czae114f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf3/11886838/4add7c6f5271/czae114f3.jpg

相似文献

1
Managing medicines in decentralization: discrepancies between national policies and local practices in primary healthcare settings in Indonesia.分权管理药品:印度尼西亚基层医疗环境中国家政策与地方实践之间的差异
Health Policy Plan. 2025 Mar 7;40(3):346-357. doi: 10.1093/heapol/czae114.
2
Healthcare workers' views on decentralized primary health care management in Lesotho: a qualitative study.莱索托卫生工作者对分散式初级卫生保健管理的看法:一项定性研究。
BMC Health Serv Res. 2024 Jul 11;24(1):801. doi: 10.1186/s12913-024-11279-3.
3
Coping with access barriers to non-communicable disease medicines: qualitative patient interviews in eight counties in Kenya.应对非传染性疾病药物获取障碍:肯尼亚 8 个县的定性患者访谈。
BMC Health Serv Res. 2021 May 3;21(1):417. doi: 10.1186/s12913-021-06433-0.
4
Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa.儿童基本癌症药物的获取情况:东非供应情况、价格和卫生系统决定因素的比较混合方法分析。
Lancet Oncol. 2023 May;24(5):563-576. doi: 10.1016/S1470-2045(23)00072-4. Epub 2023 Apr 3.
5
The availability of essential medicines in primary health centres in Indonesia: achievements and challenges across the archipelago.印度尼西亚初级卫生保健中心基本药物的可及性:群岛各地的成就与挑战
Lancet Reg Health Southeast Asia. 2024 Jan 8;22:100345. doi: 10.1016/j.lansea.2023.100345. eCollection 2024 Mar.
6
Preparedness for delivering non-communicable disease services in primary care: access to medicines for diabetes and hypertension in a district in south India.初级保健中提供非传染性疾病服务的准备情况:印度南部某地区糖尿病和高血压药物的可及性
BMJ Glob Health. 2018 Jan 3;2(Suppl 3):e000519. doi: 10.1136/bmjgh-2017-000519. eCollection 2017.
7
Bridging the gap: financing health promotion and disease prevention in Indonesia.弥合差距:印度尼西亚的健康促进和疾病预防融资。
Health Res Policy Syst. 2024 Oct 15;22(1):146. doi: 10.1186/s12961-024-01206-7.
8
Tracking health commodity inventory and notifying stock levels via mobile devices: a mixed methods systematic review.通过移动设备追踪卫生商品库存并通知库存水平:一项混合方法系统评价。
Cochrane Database Syst Rev. 2020 Oct 28;10(10):CD012907. doi: 10.1002/14651858.CD012907.pub2.
9
Collaboration for implementation of decentralisation policy of multi drug-resistant tuberculosis services in Zambia.在赞比亚合作实施耐多药结核病服务权力下放政策。
Health Res Policy Syst. 2024 Aug 19;22(1):112. doi: 10.1186/s12961-024-01194-8.
10
Views by health professionals on the responsiveness of commune health stations regarding non-communicable diseases in urban Hanoi, Vietnam: a qualitative study.越南河内市城市地区社区卫生站对非传染性疾病响应情况的卫生专业人员观点:一项定性研究
BMC Health Serv Res. 2018 May 31;18(1):392. doi: 10.1186/s12913-018-3217-4.

引用本文的文献

1
Assessing the quality of amoxicillin in the private market in Indonesia: a cross-sectional survey exploring product variety, market volume and price factors.评估印度尼西亚私营市场中阿莫西林的质量:一项探索产品种类、市场规模和价格因素的横断面调查。
BMJ Open. 2025 Jul 22;15(7):e093785. doi: 10.1136/bmjopen-2024-093785.

本文引用的文献

1
The availability of essential medicines in primary health centres in Indonesia: achievements and challenges across the archipelago.印度尼西亚初级卫生保健中心基本药物的可及性:群岛各地的成就与挑战
Lancet Reg Health Southeast Asia. 2024 Jan 8;22:100345. doi: 10.1016/j.lansea.2023.100345. eCollection 2024 Mar.
2
Regional differences in primary healthcare utilization in Java Region-Indonesia.印度尼西亚爪哇地区初级医疗保健利用的区域差异。
PLoS One. 2023 Mar 27;18(3):e0283709. doi: 10.1371/journal.pone.0283709. eCollection 2023.
3
Continuity of CVD treatment during the COVID-19 pandemic: evidence from East Java, Indonesia.
新冠疫情期间心血管疾病治疗的连续性:来自印度尼西亚东爪哇的证据。
J Pharm Policy Pract. 2023 Mar 22;16(1):50. doi: 10.1186/s40545-022-00509-w.
4
Why falsified medicines reach patients: an analysis of political and economic factors in Romania.假药为何能流入患者手中:罗马尼亚政治经济因素分析。
BMJ Glob Health. 2023 Feb;6(Suppl 3). doi: 10.1136/bmjgh-2022-009918.
5
The state of health in Indonesia's provinces, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.《1990-2019 年印度尼西亚各省的健康状况:2019 年全球疾病负担研究的系统分析》
Lancet Glob Health. 2022 Nov;10(11):e1632-e1645. doi: 10.1016/S2214-109X(22)00371-0.
6
Continuity of maternal healthcare services utilisation in Indonesia: analysis of determinants from the Indonesia Demographic and Health Survey.印度尼西亚母婴医疗服务利用的连续性:来自印度尼西亚人口与健康调查的决定因素分析。
Fam Med Community Health. 2021 Dec;9(4). doi: 10.1136/fmch-2021-001389.
7
Is Indonesia achieving universal health coverage? Secondary analysis of national data on insurance coverage, health spending and service availability.印度尼西亚是否实现了全民健康覆盖?基于保险覆盖、卫生支出和服务提供情况的国家数据的二次分析。
BMJ Open. 2021 Oct 4;11(10):e050565. doi: 10.1136/bmjopen-2021-050565.
8
What impact does medicines shortages have on patients? A qualitative study exploring patients' experience and views of healthcare professionals.药品短缺对患者有什么影响?一项定性研究探讨了患者对医护人员的体验和看法。
BMC Health Serv Res. 2021 Aug 17;21(1):827. doi: 10.1186/s12913-021-06812-7.
9
Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.评估尼日利亚阿布贾心血管、糖尿病和全球药物的可及性、价格和可负担性。
PLoS One. 2021 Aug 12;16(8):e0255567. doi: 10.1371/journal.pone.0255567. eCollection 2021.
10
Indonesian General Practitioners' Experience of Practicing in Primary Care under the Implementation of Universal Health Coverage Scheme (JKN).印度尼西亚全科医生在实施全民健康覆盖计划(JKN)下从事初级保健工作的经验。
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211023707. doi: 10.1177/21501327211023707.